Skip to main content
UniHealth

Doctor search

Lakshmi Myneni, MD

Rheumatology · Mountain View

NPI 1316028533

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2

Offices

2 locations · County of San Mateo · 316 clinicians in this group

Looking this up.

Hospitals listed: El Camino Health · San Mateo Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Myneni’s office to ask if they take your plan before you enroll.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
  • San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend it
    No overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at El Camino Health
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.291BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.393BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.96 (0.12 to 1.79) · 2,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.38 (125.03 to 209.73) · 96 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 68 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 185 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.8 · 200 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 814 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13 · 842 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 361 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 4,633 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 11,474 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,626 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.14 (1.39 to 4.9) · 2,814 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2 (0.61 to 3.39) · 1,327 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.8 to 3.43) · 2,641 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.39 (4.18 to 14.6) · 1,287 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.57 (3.47 to 9.68) · 1,308 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.14 (0.71 to 3.57) · 827 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.6 (0.05 to 1.15) · 9,460 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 122 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.993No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.706No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.376No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.5 · 218 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 962 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits3.8 · 200 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17 · 922 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18.6 · 860 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 827 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.1 (4.5 to 8.2) · 313 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.4 (10.6 to 16.5) · 313 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.7 · 237 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (10 to 16.1) · 1,639 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,619 casesNo differentJan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Patient survey stars by topic at El Camino Health
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at El Camino Health
Room was "always" clean75%
Nurses "always" communicated well79%
Doctors "always" communicated well81%
Staff "always" explained61%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for San Mateo Medical Center

Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at San Mateo Medical Center
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.34 (0.25 to 2.43) · 45 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.97 (0.48 to 1.47)No differentJul 2022 – Jun 2024
Death rate for pneumonia patientsComplications and deaths13.9 · 25 casesNoneJul 2022 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.6 · 258 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.21 (0 to 0.44) · 379 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.26 (0.05 to 0.48) · 381 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.44 (0.82 to 6.05) · 57 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.64 (0.92 to 4.37) · 57 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.53 (0 to 1.76) · 296 casesNo differentJul 2022 – Jun 2024
Clostridium Difficile (C.Diff)Infections0.661No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits21.8 · 47 casesNoneJul 2023 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-2.3 · 25 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.6 · 76 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits14 (10.4 to 18.9) · 167 casesNo differentJan 2022 – Dec 2024

What patients said (208 patients answered, 15% of those asked)

Patient survey stars by topic at San Mateo Medical Center
Cleanliness4
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital3
Share of patients giving the best answer at San Mateo Medical Center
Room was "always" clean78%
Nurses "always" communicated well76%
Doctors "always" communicated well79%
Staff "always" explained62%
Yes, staff "did" give patients this information87%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully77%
Doctors "always" treated them with courtesy and respect84%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand72%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital68%
Staff "always" explained possible side effects51%
Yes, staff "did" give patients information about possible symptoms86%

Original Medicare doctor bills

$549,944

Medicare paid this office $549,944 for 155 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, romosozumab-aqqg, 1 mg24$234,403None
Injection, denosumab, 1 mg83$157,567None
Return visit (30+ min)110$24,178$117
Short return visit (20+ min)87$17,755$83
Injection of drug or substance under skin or into muscle109$6,195$14
See all 8 services
Every Original Medicare service billed
Injection, romosozumab-aqqg, 1 mg24$234,403None
Injection, denosumab, 1 mg83$157,567None
Return visit (30+ min)110$24,178$117
Short return visit (20+ min)87$17,755$83
Injection of drug or substance under skin or into muscle109$6,195$14
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less16$2,423$67
Long return visit (40+ min)11$2,064$172
Injection, zoledronic acid, 1 mg12$325None

Who their Medicare patients are

155 Original Medicare patients in 2024. Average age 79 · Under 65 0% · 85 and older 30% · Women 79% · Health risk score 1.17. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.

Conditions among them: High blood pressure 75% · Coronary heart disease 25% · Heart failure 17% · Chronic kidney disease 17% · Atrial fibrillation 17% · Diabetes 16% · Cancer 15% · COPD 14% · Depression 10%.

The office billed $2,002,702, Medicare allowed $691,606 and paid $549,944; for 50,371 services of 32 kinds; $489,559 of it was for drugs given in the office and $60,385 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202415550,371791.17$2,002,702$549,944
202313829,697801.23$1,076,873$394,866
202214137,817811.13$1,194,735$452,345
202113126,072801.10$961,552$342,285
202012331,230791.33$1,037,819$385,413
201915320,158791.23$1,022,391$386,802
201814418,333791.24$905,148$344,760
201714817,009801.38$891,292$330,023
201613814,962801.38$830,162$292,835
201515213,522791.60$790,308$274,326
20141769,695781.56$575,990$199,545
20131858,740781.34$482,181$174,864

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 10 services

Original Medicare services billed in 2023
Injection, denosumab, 1 mg92$155,340None
Injection, romosozumab-aqqg, 1 mg16$118,081None
Return visit (30+ min)82$18,104$113
Short return visit (20+ min)95$12,379$79
Injection of drug or substance under skin or into muscle102$4,034$14
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less11$2,336$69
Long return visit (40+ min)11$2,215$170
Telephone medical discussion with physician, 11-20 minutes18$1,555$71
Short return visit17$1,388$45
Injection, methylprednisolone acetate, 40 mg13$109None

2022: 8 services

Original Medicare services billed in 2022
Injection, romosozumab-aqqg, 1 mg15$174,032None
Injection, denosumab, 1 mg84$139,654None
Return visit (30+ min)83$21,076$120
Short return visit (20+ min)90$14,364$86
Injection of drug or substance under skin or into muscle95$5,100$14
Long return visit (40+ min)24$4,312$172
Short return visit22$3,612$56
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less16$2,992$73

2021: 9 services

Original Medicare services billed in 2021
Injection, denosumab, 1 mg79$123,999None
Injection, romosozumab-aqqg, 1 mg12$51,348None
Return visit (30+ min)59$14,961$121
Short return visit (20+ min)86$11,993$88
Long return visit (40+ min)19$3,841$175
Injection of drug or substance under skin or into muscle87$3,164$14
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less13$2,833$79
Short return visit33$2,575$56
Telephone medical discussion with physician, 11-20 minutes18$1,256$60

2020: 8 services

Original Medicare services billed in 2020
Injection, denosumab, 1 mg67$85,135None
Return visit (30+ min)67$12,593$95
Short return visit (20+ min)72$7,287$67
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less15$3,536$72
Injection of drug or substance under skin or into muscle79$3,250$14
Short return visit32$2,822$43
Long return visit (40+ min)12$2,001$133
Telephone medical discussion with physician, 11-20 minutes12$992$47

2019: 9 services

Original Medicare services billed in 2019
Injection, denosumab, 1 mg73$101,522None
Return visit (30+ min)111$23,283$101
Short return visit (20+ min)80$8,555$69
Long return visit (40+ min)41$7,037$130
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less35$5,751$74
Injection of drug or substance under skin or into muscle86$2,300$16
Injection, zoledronic acid, 1 mg29$1,258None
Short return visit20$1,053$44
Injection, methylprednisolone acetate, 40 mg12$64None

2018: 10 services

Original Medicare services billed in 2018
Injection, denosumab, 1 mg79$117,845None
Return visit (30+ min)98$19,337$101
Short return visit (20+ min)85$9,044$67
Long return visit (40+ min)33$5,881$128
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less27$4,925$76
Injection of drug or substance under skin or into muscle88$3,130$21
Injection, zoledronic acid, 1 mg18$911None
Short return visit14$639$38
Administration of influenza virus vaccine15$386$26
Influenza vaccine, quadrivalent, 0.5 ml dosage15$262$17

2017: 8 services

Original Medicare services billed in 2017
Injection, denosumab, 1 mg84$105,419None
Return visit (30+ min)110$19,144$99
Long return visit (40+ min)48$9,584$135
Short return visit (20+ min)75$7,502$66
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less27$4,432$71
Injection of drug or substance under skin or into muscle91$3,771$26
Injection, zoledronic acid, 1 mg18$893None
Injection, methylprednisolone acetate, 40 mg11$76None

2016: 10 services

Original Medicare services billed in 2016
Injection, denosumab, 1 mg76$97,471None
Return visit (30+ min)89$17,384$100
Short return visit (20+ min)78$7,868$67
Long return visit (40+ min)41$6,732$135
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less24$3,700$71
Injection of drug or substance under skin or into muscle84$3,548$25
Injection, zoledronic acid, 1 mg18$1,397None
Short return visit24$1,081$42
Administration of influenza virus vaccine18$570$32
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)11$167$15

2015: 14 services

Original Medicare services billed in 2015
Injection, denosumab, 1 mg71$85,058None
Return visit (30+ min)89$14,262$96
Short return visit (20+ min)100$11,838$65
Long return visit (40+ min)35$4,577$127
Pneumococcal vaccine, 13-valent25$4,126$159
Injection of drug or substance under skin or into muscle80$3,425$25
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less19$2,965$71
Injection, zoledronic acid, 1 mg11$1,414None
Short return visit27$1,248$39
Aspiration and/or injection of fluid from large joint14$1,167$53
Administration of pneumococcal vaccine23$761$32
Administration of influenza virus vaccine13$413$32
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)13$191$15
Injection, methylprednisolone acetate, 40 mg17$72None

2014: 10 services

Original Medicare services billed in 2014
Injection, denosumab, 1 mg63$76,172None
Return visit (30+ min)86$15,683$93
Short return visit (20+ min)118$13,725$64
Long return visit (40+ min)51$7,303$130
Injection, zoledronic acid, 1 mg11$3,621None
Injection of drug or substance under skin or into muscle76$3,187$25
Short return visit36$1,743$39
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less14$1,262$70
Administration of influenza virus vaccine18$560$31
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)20$294$15

2013: 8 services

Original Medicare services billed in 2013
Injection, denosumab, 1 mg64$75,196None
Return visit (30+ min)87$15,560$93
Short return visit (20+ min)113$11,742$62
Long return visit (40+ min)66$9,778$124
Injection of drug or substance under skin or into muscle76$3,309$25
Short return visit55$2,943$38
Aspiration and/or injection of fluid from large joint11$833$52
Injection, methylprednisolone acetate, 40 mg21$86None

Drugs they prescribed that Part D paid

$101,751

Pharmacies billed $101,751 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

209 generic and fewer than 11 brand-name prescriptions · $101,751 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Humira(Cf)12$77,364$6,447
Celecoxib24$685$29
Hydroxychloroquine Sulfate12$403$34
Prednisone51$382$7
Methotrexate13$226$17
See all 6 drugs
Every Part D drug this clinician prescribed
Humira(Cf)12$77,364$6,447
Celecoxib24$685$29
Hydroxychloroquine Sulfate12$403$34
Prednisone51$382$7
Methotrexate13$226$17
Allopurinol24$134$6

Year by year

Part D prescribing by year
202424951NoneNone$101,751
202322745None21%$178,104
2022225456% (13)None$120,172
2021246467% (16)None$97,786
2020404576% (25)None$115,808
2019458616% (27)None$90,953
2018488588% (41)20%$163,122
20173765410% (39)19%$140,709
20163855613% (51)None$104,467
20155187116% (82)None$60,979
20145918111% (63)21%$75,953
20136788911% (73)21%$75,692

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 6 drugs

Part D drugs prescribed in 2023
Humira(Cf)13$97,194$7,476
Celecoxib12$839$70
Hydroxychloroquine Sulfate11$644$59
Allopurinol16$277$17
Prednisone36$244$7
Amlodipine Besylate16$161$10

2022: 5 drugs

Part D drugs prescribed in 2022
Prolia14$20,838$1,488
Allopurinol11$354$32
Prednisone27$318$12
Amlodipine Besylate19$231$12
Acetaminophen-Codeine11$144$13

2021: 5 drugs

Part D drugs prescribed in 2021
Hydroxychloroquine Sulfate14$550$39
Prednisone36$376$10
Allopurinol14$359$26
Amlodipine Besylate16$196$12
Acetaminophen-Codeine12$143$12

2020: 9 drugs

Part D drugs prescribed in 2020
Tymlos20$39,719$1,986
Prolia11$14,135$1,285
Hydroxychloroquine Sulfate27$2,316$86
Prednisone77$682$9
Alendronate19$331$17
Allopurinol25$282$11
Methotrexate11$230$21
Amlodipine Besylate33$200$6
Tramadol12$36$3

2019: 12 drugs

Part D drugs prescribed in 2019
Tymlos19$35,686$1,878
Prolia12$14,741$1,228
Hydroxychloroquine Sulfate35$5,003$143
Prednisone86$826$10
Metoprolol14$665$48
Losartan19$348$18
Allopurinol28$341$12
Gabapentin11$334$30
Methotrexate17$229$13
Alendronate21$214$10
Amlodipine Besylate23$137$6
Trazodone15$115$8

2018: 17 drugs

Part D drugs prescribed in 2018
Forteo18$61,327$3,407
Prolia11$13,244$1,204
Hydroxychloroquine Sulfate46$5,868$128
Pradaxa11$4,628$421
Colcrys12$2,577$215
Metoprolol21$1,113$53
Prednisone87$839$10
Hydrocodone-Acetaminophen20$573$29
Olmesartan Medoxomil12$571$48
Azathioprine11$442$40
Allopurinol34$403$12
Methotrexate17$262$15
Atorvastatin11$220$20
Acetaminophen-Codeine14$181$13
Amlodipine Besylate22$140$6
Furosemide13$59$5
Trazodone14$51$4

2017: 10 drugs

Part D drugs prescribed in 2017
Esbriet12$102,804$8,567
Prolia11$11,776$1,071
Hydroxychloroquine Sulfate35$6,515$186
Acyclovir11$662$60
Methotrexate25$576$23
Prednisone65$522$8
Hydrocodone-Acetaminophen29$404$14
Allopurinol11$158$14
Furosemide12$45$4
Trazodone11$33$3

2016: 11 drugs

Part D drugs prescribed in 2016
Forteo13$32,116$2,470
Hydroxychloroquine Sulfate32$5,226$163
Celecoxib11$1,971$179
Hydrocodone-Acetaminophen35$833$24
Prednisone58$505$9
Methotrexate18$501$28
Azathioprine13$283$22
Potassium Chloride11$251$23
Tramadol14$189$13
Paroxetine11$157$14
Furosemide15$44$3

2015: 13 drugs

Part D drugs prescribed in 2015
Prolia16$15,254$953
Uloric20$5,078$254
Hydroxychloroquine Sulfate37$4,773$129
Prednisone97$855$9
Hydrocodone-Acetaminophen54$803$15
Azathioprine20$524$26
Methotrexate18$460$26
Potassium Chloride12$390$32
Tramadol23$247$11
Gabapentin18$169$9
Paroxetine16$156$10
Alendronate11$95$9
Amlodipine Besylate14$67$5

2014: 15 drugs

Part D drugs prescribed in 2014
Prolia16$13,803$863
Colcrys21$5,181$247
Uloric17$5,172$304
Hydroxychloroquine Sulfate40$1,436$36
Prednisone129$1,282$10
Methotrexate21$757$36
Hydrocodone-Acetaminophen27$555$21
Tramadol34$545$16
Azathioprine16$328$21
Alendronate24$222$9
Gabapentin16$208$13
Amlodipine Besylate20$139$7
Paroxetine12$126$11
Bd Ultra-Fine Pen Needle11$113$10
Citalopram Hbr12$57$5

2013: 17 drugs

Part D drugs prescribed in 2013
Enbrel11$26,022$2,366
Prolia17$14,172$834
Colcrys22$3,408$155
Namenda12$1,630$136
Methotrexate31$1,475$48
Hydroxychloroquine Sulfate35$763$22
Tramadol40$745$19
Prednisone114$705$6
Hydrocodone-Acetaminophen15$356$24
Gabapentin13$264$20
Losartan21$248$12
Amlodipine Besylate36$244$7
Simvastatin17$172$10
Levothyroxine19$143$8
Allopurinol14$111$8
Citalopram Hbr16$87$5
Trazodone14$60$4

Money from drug and device companies

$1,523 in 2025

Industry payments by year
20251230None$1,523
2024819$1,680$2,170
20231022None$1,924
2022816None$634
20211019None$464
2020816None$465
20191637None$1,288

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AbbvieSkyrizi$462
8 payments
  • Meals for Rinvoq · 2025-12-20 · $19
  • Meals for Skyrizi · 2025-12-05 · $21
  • Meals for Skyrizi · 2025-11-20 · $122
  • Meals for Rinvoq · 2025-10-27 · $15
  • Meals for Skyrizi · 2025-10-03 · $21
  • Meals · 2025-08-28 · $122
  • Meals for Skyrizi · 2025-08-08 · $16
  • Meals for Rinvoq · 2025-04-24 · $125
AmgenEvenity$255
7 payments
  • Meals for Evenity · 2025-12-19 · $20
  • Meals for Evenity · 2025-11-11 · $124
  • Meals for Tavneos · 2025-08-22 · $23
  • Meals for Evenity · 2025-07-26 · $23
  • Meals for Krystexxa · 2025-06-10 · $19
  • Meals for Krystexxa · 2025-04-18 · $19
  • Meals for Tavneos · 2025-04-11 · $28
Janssen BiotechTremfya$206
3 payments
  • Meals for Tremfya · 2025-08-29 · $36
  • Meals for Tremfya · 2025-08-29 · $34
  • Meals for Tremfya · 2025-06-04 · $136
InSightecExablate$143
1 payment
  • Meals for Exablate · 2025-08-26 · $143
UcbBimzelx$125
1 payment
  • Meals for Bimzelx · 2025-04-17 · $125
Mayne Pharma CommercialBijuva$122
1 payment
  • Meals for Bijuva · 2025-08-20 · $122
See all 30 published payments
Every published payment
AbbvieMeals · 2025-12-20Rinvoq$19
AmgenMeals · 2025-12-19Evenity$20
AbbvieMeals · 2025-12-05Skyrizi$21
AbbvieMeals · 2025-11-20Skyrizi$122
Exact SciencesMeals · 2025-11-14None$28
AmgenMeals · 2025-11-11Evenity$124
AstraZeneca Pharmaceuticals LPMeals · 2025-10-30Saphnelo$23
AbbvieMeals · 2025-10-27Rinvoq$15
Mallinckrodt Hospital ProductsMeals · 2025-10-17Acthar$26
AbbvieMeals · 2025-10-03Skyrizi$21
Janssen BiotechMeals · 2025-08-29Tremfya$36
Janssen BiotechMeals · 2025-08-29Tremfya$34
AbbvieMeals · 2025-08-28None$122
InSightecMeals · 2025-08-26Exablate$143
AstraZeneca Pharmaceuticals LPMeals · 2025-08-25Saphnelo$20
AmgenMeals · 2025-08-22Tavneos$23
Mayne Pharma CommercialMeals · 2025-08-20Bijuva$122
PfizerMeals · 2025-08-15Xeljanz$20
AbbvieMeals · 2025-08-08Skyrizi$16
AmgenMeals · 2025-07-26Evenity$23
Exact SciencesMeals · 2025-07-22The Cologuard Plus Collection Kit$20
AmgenMeals · 2025-06-10Krystexxa$19
Janssen BiotechMeals · 2025-06-04Tremfya$136
Lilly USAMeals · 2025-04-24Kisunla$17
AbbvieMeals · 2025-04-24Rinvoq$125
AmgenMeals · 2025-04-18Krystexxa$19
UcbMeals · 2025-04-17Bimzelx$125
AmgenMeals · 2025-04-11Tavneos$28
Aurinia Pharma U.S.Meals · 2025-04-05Lupkynis$28
PfizerMeals · 2025-01-10Xeljanz$27
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $2,170

Payments by company in 2024
Janssen BiotechTremfya$1,751
3 payments
  • Consulting for Tremfya · 2024-06-21 · $1,680
  • Meals for Tremfya · 2024-06-15 · $54
  • Meals for Tremfya · 2024-02-09 · $17
AmgenEvenity$193
8 payments
  • Meals for Evenity · 2024-12-06 · $33
  • Meals for Evenity · 2024-10-24 · $23
  • Meals for Tavneos · 2024-10-11 · $19
  • Meals for Krystexxa · 2024-06-07 · $17
  • Meals for Evenity · 2024-05-31 · $23
  • Meals for Tavneos · 2024-04-05 · $33
  • Meals for Evenity · 2024-02-23 · $27
  • Meals for Krystexxa · 2024-01-26 · $18
AstraZeneca Pharmaceuticals LPSaphnelo$63
2 payments
  • Meals for Saphnelo · 2024-04-23 · $30
  • Meals for Saphnelo · 2024-04-19 · $33
PfizerXeljanz$53
2 payments
  • Meals for Xeljanz · 2024-08-17 · $24
  • Meals for Xeljanz · 2024-03-08 · $29
GlaxoSmithKlineBenlysta$32
1 payment
  • Meals for Benlysta · 2024-11-08 · $32
AbbvieRinvoq$27
1 payment
  • Meals for Rinvoq · 2024-01-13 · $27
Radius HealthTymlos$26
1 payment
  • Meals for Tymlos · 2024-05-10 · $26
Lilly USANone$26
1 payment
  • Meals · 2024-10-15 · $26

2023: $1,924

Payments by company in 2023
US Oncology CorporateNone$1,139
5 payments
  • Travel · 2023-02-23 · $527
  • Travel · 2023-02-23 · $303
  • Travel · 2023-02-23 · $169
  • Travel · 2023-02-23 · $23
  • Meals · 2023-02-23 · $117
AmgenProlia$186
5 payments
  • Meals for Evenity · 2023-08-16 · $18
  • Meals for Evenity · 2023-04-28 · $26
  • Meals for Prolia · 2023-04-13 · $101
  • Meals for Evenity · 2023-03-03 · $23
  • Meals for Evenity · 2023-01-20 · $17
AstraZeneca Pharmaceuticals LPSaphnelo$167
4 payments
  • Meals for Saphnelo · 2023-12-14 · $132
  • Meals for Saphnelo · 2023-12-08 · $4
  • Meals for Saphnelo · 2023-12-08 · $13
  • Meals for Saphnelo · 2023-07-07 · $19
Novartis PharmaceuticalsNone$153
1 payment
  • Meals · 2023-11-12 · $153
UcbCimzia$125
1 payment
  • Meals for Cimzia · 2023-04-27 · $125
Radius HealthTymlos$51
2 payments
  • Meals for Tymlos · 2023-07-29 · $25
  • Meals for Tymlos · 2023-02-11 · $27
Aurinia Pharma U.S.Lupkynis$30
1 payment
  • Meals for Lupkynis · 2023-06-15 · $30
Horizon Therapeutics plcKrystexxa$26
1 payment
  • Meals for Krystexxa · 2023-10-06 · $26
PfizerXeljanz$25
1 payment
  • Meals for Xeljanz · 2023-05-03 · $25
Janssen BiotechTremfya$20
1 payment
  • Meals for Tremfya · 2023-03-10 · $20

2022: $634

Payments by company in 2022
Radius HealthTymlos$206
4 payments
  • Meals for Tymlos · 2022-10-13 · $33
  • Meals for Tymlos · 2022-10-12 · $120
  • Meals for Tymlos · 2022-07-16 · $24
  • Meals for Tymlos · 2022-02-11 · $29
Sun Pharmaceutical IndustriesCequa$195
1 payment
  • Meals for Cequa · 2022-09-09 · $195
Janssen BiotechTremfya$68
3 payments
  • Meals for Tremfya · 2022-11-11 · $26
  • Meals for Tremfya · 2022-01-15 · $15
  • Meals for Tremfya · 2022-01-14 · $26
AmgenProlia$46
2 payments
  • Meals for Prolia · 2022-09-09 · $24
  • Meals for Evenity · 2022-01-28 · $22
Genentech USAOcrevus$42
2 payments
  • Meals for Rituxan · 2022-04-15 · $19
  • Meals for Ocrevus · 2022-03-25 · $23
Novartis PharmaceuticalsCosentyx$40
2 payments
  • Meals for Cosentyx · 2022-08-26 · $17
  • Meals for Cosentyx · 2022-02-04 · $24
AstraZeneca Pharmaceuticals LPSaphnelo$20
1 payment
  • Meals for Saphnelo · 2022-08-12 · $20
AbbvieRinvoq$18
1 payment
  • Meals for Rinvoq · 2022-08-03 · $18

2021: $464

Payments by company in 2021
GlaxoSmithKlineBenlysta$108
2 payments
  • Meals for Benlysta · 2021-06-06 · $90
  • Meals for Benlysta · 2021-04-08 · $18
AmgenEvenity$77
4 payments
  • Meals for Evenity · 2021-12-03 · $28
  • Meals for Evenity · 2021-10-21 · $13
  • Meals for Evenity · 2021-10-08 · $18
  • Meals for Avsola · 2021-03-17 · $18
PfizerXeljanz$70
3 payments
  • Meals for Xeljanz · 2021-08-20 · $23
  • Meals for Xeljanz · 2021-04-02 · $25
  • Meals · 2021-03-25 · $23
Radius HealthTymlos$61
3 payments
  • Meals for Tymlos · 2021-10-16 · $23
  • Meals for Tymlos · 2021-08-28 · $18
  • Meals for Tymlos · 2021-04-30 · $19
AbbVieRinvoq$39
2 payments
  • Meals for Rinvoq · 2021-10-23 · $15
  • Meals for Rinvoq · 2021-05-29 · $24
Janssen BiotechTremfya$36
1 payment
  • Meals for Tremfya · 2021-11-12 · $36
Mallinckrodt Hospital ProductsActhar$30
1 payment
  • Meals for Acthar · 2021-02-20 · $30
GenzymeFabrazyme$16
1 payment
  • Meals for Fabrazyme · 2021-04-23 · $16
Myriad Genetic LaboratoriesMyrisk$15
1 payment
  • Meals for Myrisk · 2021-10-28 · $15
Merck Sharp & DohmeRenflexis$11
1 payment
  • Meals for Renflexis · 2021-03-15 · $11

2020: $465

Payments by company in 2020
AmgenEvenity$128
5 payments
  • Meals for Evenity · 2020-12-04 · $34
  • Meals for Evenity · 2020-09-29 · $13
  • Meals for Evenity · 2020-08-28 · $26
  • Meals for Evenity · 2020-07-10 · $28
  • Meals for Evenity · 2020-02-28 · $26
AllerganNone$125
1 payment
  • Meals · 2020-03-05 · $125
Mallinckrodt Hospital ProductsActhar$68
3 payments
  • Meals for Acthar · 2020-11-06 · $26
  • Meals for Acthar · 2020-07-25 · $24
  • Meals for Acthar · 2020-03-06 · $17
GenzymeKevzara$47
2 payments
  • Meals for Kevzara · 2020-09-18 · $25
  • Meals for Kevzara · 2020-07-14 · $22
PfizerXeljanz$40
2 payments
  • Meals for Xeljanz · 2020-07-17 · $19
  • Meals for Xeljanz · 2020-02-07 · $21
AbbVieHumira$29
1 payment
  • Meals for Humira · 2020-09-25 · $29
Novartis PharmaceuticalsCosentyx$15
1 payment
  • Meals for Cosentyx · 2020-08-07 · $15
Radius HealthTymlos$13
1 payment
  • Meals for Tymlos · 2020-09-11 · $13

2019: $1,288

Payments by company in 2019
Radius HealthTymlos$309
4 payments
  • Meals for Tymlos · 2019-10-18 · $26
  • Meals for Tymlos · 2019-07-23 · $125
  • Meals for Tymlos · 2019-06-08 · $33
  • Meals for Tymlos · 2019-04-09 · $125
AbbVieHumira$171
3 payments
  • Meals for Humira · 2019-08-26 · $125
  • Meals for Humira · 2019-05-24 · $21
  • Meals for Humira · 2019-03-29 · $25
GenzymeKevzara$169
4 payments
  • Meals for Kevzara · 2019-11-22 · $22
  • Meals for Kevzara · 2019-09-16 · $125
  • Meals for Kevzara · 2019-06-28 · $15
  • Meals for Fabrazyme · 2019-05-07 · $7
AstraZeneca Pharmaceuticals LPFasenra$125
1 payment
  • Meals for Fasenra · 2019-06-19 · $125
Mallinckrodt EnterprisesActhar$96
4 payments
  • Meals for Acthar · 2019-11-21 · $18
  • Meals for Acthar · 2019-10-25 · $22
  • Meals for Acthar · 2019-05-03 · $26
  • Meals for Acthar · 2019-02-15 · $30
AmgenEvenity$68
3 payments
  • Meals for Evenity · 2019-12-11 · $16
  • Meals for Evenity · 2019-06-12 · $29
  • Meals for Evenity · 2019-05-13 · $23
UcbCimzia$60
2 payments
  • Meals for Cimzia · 2019-11-15 · $31
  • Meals for Cimzia · 2019-09-18 · $29
Horizon Therapeutics plcKrystexxa$52
2 payments
  • Meals for Krystexxa · 2019-10-04 · $30
  • Meals for Krystexxa · 2019-07-19 · $22
Janssen BiotechSimponi Aria$51
3 payments
  • Meals for Simponi Aria · 2019-05-02 · $17
  • Meals for Simponi · 2019-03-08 · $12
  • Meals for Simponi Aria · 2019-02-22 · $22
Alexion PharmaceuticalsStrensiq$47
3 payments
  • Meals for Strensiq · 2019-11-01 · $13
  • Meals for Soliris · 2019-04-19 · $18
  • Meals for Strensiq · 2019-04-05 · $15
Novartis PharmaceuticalsCosentyx$36
2 payments
  • Meals for Cosentyx · 2019-12-09 · $17
  • Meals for Cosentyx · 2019-01-11 · $19
PfizerInflectra$29
2 payments
  • Meals · 2019-12-06 · $13
  • Meals for Inflectra · 2019-07-26 · $16
Lilly USANone$25
1 payment
  • Meals · 2019-02-02 · $25
Sun Pharmaceutical IndustriesIlumya$20
1 payment
  • Meals for Ilumya · 2019-01-25 · $20
Grifols USAGamunex-C$17
1 payment
  • Meals for Gamunex-C · 2019-04-12 · $17
GlaxoSmithKlineBenlysta$15
1 payment
  • Meals for Benlysta · 2019-06-14 · $15

Professional record

NPI
1316028533
Licence
CA A049704
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 207RR0500X (207RR0500X)
Mailing address
2490 Hospital Dr Ste 102, Mountain View, CA, 94040
NPI first listed
2006-10-17
NPI last updated
2021-04-05
NPI record certified
2021-04-05

This is when the NPI record was last certified, not a medical board exam.